HEMATOPEDIA

ANNUAL SAUDI HEMATOLOGY CONGRESS

AGENDA
SCIENTIFIC PROGRAM
DAY 1
6th Saudi Hematology Research Day
4 March 2021, Thursday (7:30-10:15 PM) KSA Time

KSA TIME MINS SESSION TITLE PRESENTER

19:30-19:35 5 Conference Chairman Speech Naeem Chaudhri

19:35-19:40 5 SSBD Welcome Address Fahad Almohareb

Session I Moderator: Ahlam Almasari (KSA) & Muhaned Alhumaid (KSA)

19:40-19:48

19:48-19:56

19:56-20:04

20:04-20:12

20:12-20:20 80

(8 mins
20:20-20:28 each)
20:28-20:36

20:36-20:44

20:44-20:52

20:52-21:00

21:00-21:15 15 Poster Display Session

21:15-21:50 35 Awarding Ceremony and E-recognition of ASHC 2021 Sponsors

21:50-22:15 25 Advances in R/R CLL Management (Abbvie Satellite Talk) John Gribben (UK)

*Virtual Exhibition is only open to registered congress participants and available during the congress session with
timing above.

End of Day 1
 HEMATOPEDIA

ANNUAL SAUDI HEMATOLOGY CONGRESS

AGENDA
DAY 2
Malignant Hematology
5 March 2021, Friday (3:00-6:50 PM) KSA Time

KSA TIME MINS SESSION TITLE PRESENTER

Opening Ceremony
15:00-15:05 5 Welcome Address (SSBD President) Feras Alfraih
Dr. Mohammed Alabdulaali

15:05-15:15 10 Opening Remarks (Distinguished Guest) Assistant Minister

Saudi Ministry of Health

15:15-15:20 5 Opening Remarks (Scientific Committee Chair) Riad Elfakih
Session I Moderator: Feras Alfraih (KSA)
Current Trends and Advances in Frontline Management of
15:20-15:45 25 Wendy Stock (USA)
ALL

Role of Immunotherapy in MRD+ Adult Acute Chair: Feras Alfraih (KSA)

15:45-16:10 25
Lymphoblastic Leukemia (Amgen Satellite Talk) Nicola G ökbuget (Germany)
The Burden of AML - Mutations and Prognostic
16:10-16:35 25 Naval Daver (USA)
Implications (Astellas Satellite Talk)
16:35-16:50 15 Q&A
16:50-18:40 Opening of the Virtual Exhibition
16:50-17:05 15 Break
Session II Moderator: Nawal Alshehry (KSA)
17:05-17:30 25 New Therapeutics and New Targets in MDS Rami Komrokji (USA)
17:30-17:55 25 MRD Testing in AML: Is it Ready for Prime Time? Brent Wood (USA)
17:55-18:20 25 Progress in AML 2021 at MD Anderson Hagop Kantarjian (USA)
18:20-18:35 15 Q&A
18:35-16:50 15 Virtual Exhibition
*Virtual Exhibition is only open to registered congress participants and available during the congress session with
timing above.

End of Day 2
 HEMATOPEDIA

ANNUAL SAUDI HEMATOLOGY CONGRESS

AGENDA
DAY 3
Malignant Hematology
6 March 2021, Saturday (3:00-6:50 PM) KSA Time

KSA TIME MINS SESSION TITLE PRESENTER

15:00-15:05 5 Opening Remarks (KFSH&RC) Mahmoud Aljurf

15:05-15:10 5 Welcome Address (SSBD) Amal Albeihany
Session I Moderator: Amal Alabdulwahab (KSA)
15:10-15:35 25 Are we sitting on a cure for MM? Philippe Moreau (France)
15:35-16:00 25 Is combination therapy ready for prime time in CML? Jorge Cortes (USA)
16:00-16:25 25 Are we sitting on a cure for CLL? William Wierda (USA)
16:25-16:40 15 Q&A
16:40-18:50 Opening of the Virtual Exhibition
16:40-16:55 15 Break
Session II Moderator: John Apostolidis (KSA)
What is the future of immunotherapies for T-cell
16:55-17:20 25 Francine Foss (USA)
Lymphomas?
Are targeted and immunotherapy regimens going to
17:20-17:45 25 replace platinum-based regimens and autologous James Armitage (USA)
transplantation for salvage in cHL?
17:45-18:00 15 Q&A

Redefining CLL Standard of Care in 2021 (Janssen Satellite Chair: TBD

18:00-18:25 25
Talk) Carol Moreno (Spain)
Invasive Fungal Disease in Hematology Patients - New
18:25-18:50 25 Varun Mehra (UK)
Frontiers (Gilead Satellite Talk)
*Virtual Exhibition is only open to registered congress participants and available during the congress session with
timing above.

End of Day 3
 HEMATOPEDIA

ANNUAL SAUDI HEMATOLOGY CONGRESS

AGENDA
DAY 4
Innovations in Hematology
7 March 2021, Sunday (7:30-10:30 PM) KSA Time

KSA TIME MINS SESSION TITLE PRESENTER

19:30-19:35 5 Opening Remarks (SSBD) Ali A Alahmari (PHO)

19:35-19:40 5 Welcome Address (KFSH&RC) Syed Osman Ahmed

Session 1 Moderator: Ali A Alahmari (KSA)

19:40-20:05 25 Emerging Gene Therapy for Hemoglobinopathies Stuart Orkin (USA)

20:05-20:30 25 Current and Future Gene Therapy in Hemophilia John Pasi (UK)

20:30-20:55 25 Off-the-shelf Allogeneic CART Cells Reuben Benjamin (UK)

20:55-21:10 15 Q&A

21:10-22:30 Opening of the Virtual Exhibition

21:10-21:25 15 Break

Session 2 Moderator: Abdelwahab Albabtain (KSA)

21:25-21:50 25 CAR- NK vs CAR-T: Similarities and Differences Rafet Basar (USA)

Individualized Approaches to Treatment Selection for Chair: TBD

21:50-22:15 25
NDMM Transplant Eligible (Janssen Satellite Talk) Maria Mateos (Spain)

22:15-22:30 15 Q&A

*Virtual Exhibition is only open to registered congress participants and available during the congress session with
timing above.

End of Day 4
 HEMATOPEDIA

ANNUAL SAUDI HEMATOLOGY CONGRESS

AGENDA
DAY 5
Innovations in Hematology
8 March 2021, Monday (7:30-10:30 PM) KSA Time

KSA TIME MINS SESSION TITLE PRESENTER

19:30-19:35 5 Opening Remarks (KFSH&RC) Marwan Shaheen

19:35-19:40 5 Welcome Address (KFSH&RC) Ali D Alahmari (AH)

Session 1 Moderator: Mohamad Almakadi (KSA)

Clinical Applications of A.I. and Machine Learning in

19:40-20:05 25 Feras Alfraih (KSA)
Hematology; Opportunities and Challenges

Transforming Diagnostic Malignant Hematology Through

20:05-20:30 25 Mohammed Salama (USA)
A.I.

Updates on Therapeutic Innovations on CLL (Sponsored by

20:30-20:55 25 Jennifer Brown (USA)
AstraZeneca)

20:55-21:10 15 Q&A

21:10-22:30 Opening of the Virtual Exhibition

21:10-21:25 15 Break

Session 2 Moderator: Alfadel Alshaibani (KSA)

Artificial Intelligence Approaches in Hematopoietic Cell

21:25-21:50 25 Shahrukh Hashmi (UAE)
Transplantation

CAR-T Therapy: Changing the Treatment Paradigm in R/R

21:50-22:15 25 Paolo Corradini (Italy)
DLBCL (Novartis Satellite Talk)

22:15-22:30 15 Q&A

*Virtual Exhibition is only open to registered congress participants and available during the congress session with
timing above.

End of Day 5
 HEMATOPEDIA

ANNUAL SAUDI HEMATOLOGY CONGRESS

AGENDA
DAY 6
Benign Hematology and Transfusion Medicine
9 March 2021, Tuesday (7:30-10:55 PM) KSA Time

KSA TIME MINS SESSION TITLE PRESENTER

19:30-19:35 5 Opening Remarks (SSBD/MENA-HL President) Ahmed Tarawah

19:35-19:40 5 Welcome Address (Scientific Committee Chair) Tarek Owaidah

Session 1 Moderator: Bader Rawahi (Oman)

19:40-20:05 25 The Impact of Available PK on Management of Hemophilia Alfonso Iorio (Canada)

Is There a Difference in Tests for Monitoring Infused Factor

20:05-20:30 25 Steve Kitchen (UK)
8?

20:30-20:55 25 Convalescent Plasma and Its Use in COVID-19 Patients Giovanni Di Minno (Italy)

20:55-21:10 15 Q&A

21:10-22:55 Opening of the Virtual Exhibition

21:10-21:25 15 Break

Session 2 Moderator: Abdulkareem Almomen (KSA)

21:25-21:50 25 The Future Care of Hemoglobinopathies in KSA Hatoon Ezzat (KSA)

21:50-22:15 25 Hemophilia (Takeda Satellite Talk) Johnny Mahlangu (S. Africa)

ß -Thalassemia: Burden and Updates in Management (BMS

22:15-22:40 25 Ali Taher (Lebanon)
Satellite Talk)

22:40-22:55 15 Q&A

*Virtual Exhibition is only open to registered congress participants and available during the congress session with
timing above.

End of Day 6
 HEMATOPEDIA

ANNUAL SAUDI HEMATOLOGY CONGRESS

AGENDA
DAY 7
Benign Hematology and Transfusion Medicine
10 March 2021, Wednesday (7:30-10:30 PM) KSA Time

KSA TIME MINS SESSION TITLE PRESENTER

19:30-19:35 5 Opening Remarks (KFSH&RC) Hazzaa Alzahrani

19:35-19:40 5 Welcome Address (SSBD) Mohammed Almohammadi

Session 1 Moderator: Murtadha Al-Khabori (Oman)

19:40-20:05 25 New Indications for DOAC Thomas Ortel (USA)

20:05-20:30 25 Coagulation Changes in Adults with COVID-19 Armando Tripodi (Italy)

20:30-20:55 25 Rare Bleeding Disorders Molecular Phenotypic Correlation Flora Peyvandi (Italy)

20:55-21:10 15 Q&A

21:10-23:00 Opening of the Virtual Exhibition

21:10-21:25 15 Break

Session 2 Moderator: Hazzaa Alzahrani (KSA)

Practical Aspects of Reversal of Direct Acting Oral

21:25-21:50 25 Mark Crowther (Canada)
Anticoagulants

21:50-22:15 25 aTTP Management Updates (Sanofi Satellite Talk) Paul Coppo (France)

22:15-22:30 15 Q&A

*Virtual Exhibition is only open to registered congress participants and available during the congress session with
timing above.

End of Day 7